1Eigler N L, Sacca and R S, Sherwin. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia[ J]. J Clin Invest, 1979, 63(1) :114-123.
2Shamoon H, Hendler R, Sherwin RS. Synergistic interactions a- mong antiinsulin hormones in the pathogenesis of stress hyperglyce- mia in humans[J]. J Clin Endocrinol Metab, 1981, 52(6) :1235- 1241.
3Campbell RK, Etiology and effect on outcomes of hyperglycemia in hospitalized patients[J]. Am J Health Syst Pharm, 2007, 64:4-8.
4Trick WE, Scheckler WE, Tokars JI, et 81. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting[ J ]. J Thorac Cardiovasc Surg, 2000, 119 ( 1 ) : 108-114.
5Moghissi ES, Kurytkowski MT, DiNardo M, et al. American Asso- ciation of Clinical Endocrinologists and American Diabetes Associa- tion consensus statement on inpatient glycemic control[ J]. Diabetes Care, 2009, 32(6) :1119-1131.
6Mogbissi ES. Reexamining the evidence for inpatient glucose con- trol: new recommendations for glycemic targets [ J]. Am J Health Syst Pharm, 2010, 67:3-8.
7Qaseem A, Humphrey LL, Chou R, et al. Use of intensive insulintherapy for the management of glycemic control in hospitalized pa- tients: a clinical practice guideline from the American College of Physicians[J]. Ann Intern Med, 2011, 154(4) :260-267.
8Dhatafiya K, Levy N, Kilvert A, et al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes[ J]. diabete Med, 2012, 29(4) :420-433.
9Desai SP, Henry LL, Holmes SD, et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial [ J ]. J Thorae Cardiovasc Surg, 2012, 143(2) :318-325.
10Dronge AS, Perkal MF, Kaneir S, et al. Long-term glycemie control and postoperative infectious complications [ J ]. Arch Surg, 2006, 14l (4) :375-380.
